With over 30 years of experience in the powder handling and containment industry, Carl Andrews will help us do what it is we do best: custom systems that solve real problems for our clients.
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), a business unit of Johnson Matthey Fine Chemical Division (LSE: JMAT), has announced an expansion to its proprietary tethered catalyst technology, and is now offering multi-kilogram quantities for application in commercial processes.
World Courier, an AmerisourceBergen® (NYSE: ABC) company, today announced that World Courier Italy has been accepted as a member of the Italian Association for the Development of Biotechnology (Assobiotec) after a challenging election process.
As of January 2014, Stephan Reuter, 44, is the new CEO of OPTIMA Pharma GmbH in Mornshausen, a worldwide known manufacturer of high-quality, innovative freeze-drying systems for the pharmaceutical and biotechnology industries.
SCHOTT is supporting the pharmaceutical industry in its efforts to track the tubing used to produce pharmaceutical packaging made of glass. The company issued its 1 millionth certificate for its FIOLAX® glass tubing just recently.
SHL will be attending the upcoming 18th annual Drug Delivery Partnerships conference event in Bota Raton, Florida USA, where marketing director Steven Kaufman will speak on the topic of recent and upcoming trends in drug delivery devices such as auto injectors and pen injectors.
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), a business unit of Johnson Matthey Fine Chemical Division (LSE: JMAT), has announced an expansion to its proprietary tethered catalyst technology, and is now offering multi-kilogram quantities for application in commercial processes.
Haselmeier announced the addition of Terence O’Hagan as Director of Business Development, based in the United States. Previously, he was the Senior Director of Business Development at Flextronics Medical Division, and Global Director of Strategy and Business Development at Radius Product Development.
According to a recent industry report, more than 75% of biologics are administered either subcutaneously or intramuscularly via a form of drug delivery technology, and with the continuous surge of biologics in biopharma company pipelines worldwide, the drug delivery technologies market is anticipated to grow to over $224billion USD in the next few years.
World Courier, an AmerisourceBergen (NYSE: ABC) company, today announces the upcoming expansion of the World Courier Ground Europe (WCGE) fleet.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.